Priority Approval/Registration of Favipiravir Drugs During the COVID-19 Pandemic

Pakistan (National)

Issuing Authority: Drug Regulatory Authority

Type: Law/Policy Document

July 14, 2020 (issued)

Download Law/Policy Document